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Abstract 
The identification of monoclonal immunoglobulins is important in the diagnosis and 
management ofsome B cell tumours. It is difficult to distinguish between oligoclonal 
bands and small monoclonal bands by routine protein electrophoresis. 
This is even more of a problem in Hong Kong than many other countries because of 
a high incidence of cirrhosis which is one of the conditions associated with 
oligoclonal bands. Immunofixation electrophoresis (ff"E) can be used to help 
distinguish these bands but antiserum is quite expensive. Another method with high 
sensitivity and specificity for detecting abnormal IgG bands is isoelectric focusing. 
This method is not sensitive for detecting abnormal IgA and IgM bands and therefore 
cannot be used for initial screening. It is cheaper than immunofixation because 
expensive antiserum is not required. 
Fifty samples which had been found to have monoclonal, oligoclonal or polyclonal 
bands by protein electrophoresis and immunofixation were reanalysed by EEF without 
knowing the reported result. There was agreement between the two methods as to 
which electrophoretic patterns showed no abnormality of IgG. However it was found 
that ffiF distinguished more clearly between oligoclonal and monoclonal IgG than 
IFE. We recommend this as a cheap method for further investigating bands which do 
not have a typical appearance of a monoclonal band. It can reduce the number of 



















Monoclonal immunoglobulin is comprised of intact or fragmented immunoglobulin 
molecules, which are homogenous in structure and originate from a single clone of B 
cells. The identification of monoclonal immunoglobulin is important in the diagnosis 
and management of some B cell tumors (e.g. myeloma). It is difficult to distinguish 
between oligoclonal bands and small monoclonal bands by routine protein 
electrophoresis. This is even more of a problem in Hong Kong than many other 
countries, because of a high incidence of cirrhosis, which is one of the conditions 
associated with oligoclonal bands. In this chapter, the history of identification of 
monoclonal protein, the current knowledge of physiology of immunoglobulin, the 
pathology of monoclonal immunoglobulin and the diseases associated with the 
monoclonal immunoglobulin are reviewed. It also reviews the different techniques for 
detecting this protein. Finally, the aim of the present study is described. 
1 • 1 History 
In 1845, Bence -Jones protein was found in the urine of a patient with severe back 
pain. Dr Henry Bence Jones made the earliest description of abnormally occurring 
protein in urine, associated with myeloma, which preceded recognition of the disease, 
in a lecture given to the Royal College of Physicians in 1846. Another patient with 
bone disease was studied in Amsterdam twenty -two years later and the urine of this 
patient contained the same type of urinary protein described by Bence Jones [1, 2]. 
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There was little progress in the further characterization of this protein until Tiselius 
in 1937 separated serum globulins by electrophoresis into three components: alpha, 
beta, and gamma globulins [7]. Apitz in 1940 introduced the term paraprotein to 
describe the abnormal proteins in blood, urine and tissues that are produced by 
myeloma cells [2，48]. Electrophoresis on a substrate of paper (by the 1950s) or starch 
gel[l] and later on cellulose acetate and agarose, greatly advanced the study of the 
disease. The term ’ M-protein , was proposed by Riva in 1957 to designate the sharp 
peak or band of protein of homogenous isoelectric point that appeared in the serum 
protein electrophoresis of patients with myeloma and the letter 'M' agreed with the 
later determination that these proteins were monoclonal [1]. 
Grabar and Williams in 1953 devised the technique of immunoelectrophoresis which 
was later adapted to detect monoclonal immunoglobulin [14]. Immunofixation which 
was first used by Ritchie and Smith in 1976 [3，4] is now a common method in 
identifying monoclonal proteins with greater sensitivity and specificity than 
immunoelectrophoresis. Immunoisoelectric focusing was developed by Sinclair et al 




It has long been recognized that those immunoglobulins, sometimes referred to as 
"gamma globulins" migrate in the beta and alpha-2 mobility regions as well as in the 
gamma region. The basic monomeric unit of immunoglobulins is an Y-shaped 
molecule consisting of two identical heavy chains and two identical light chains (Fig. 
1) [2, 7, 84]. There are five classes of heavy chains designated by Greek small lower-
case letters (y, a， i^, 5，e) occurring in IgG, IgA, IgM, IgD, and IgE respectively and 
two types oflight chains (K and X). 
In any given immunoglobulin molecule, there is only one type of heavy chain and 
only one type of light chain. Heavy and light chains are composed of related 
'domains'; both have a single variable region domain and the light chain has a single 
constant region domain while the heavy chain has three or four constant region 
domains depending the class. Disulphide bonds link usually four polypeptide chains. 
The name of the immunoglobulin is taken from the combination of the heavy and 
light chain designations. The properties of the five major immunoglobulin molecules 
are listed in Table 1 [7, 8]. 
There are approximately 110 residues at the amino terminal ends of each light and 
heavy chain constituting a region where the amino acid sequences differ considerably. 
This is the site called the variable or 'V' region that determines the 'idiotype' or unique 
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Fig. 1 The basic monoclonal unit of immunoglobul ins [ref 7] 
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Table 1 Properties of plasma immunoglobulins [ r e f 2 , 7] 
Properties IgG IgA IgM IgD IgE 
Molecuhr weight 150000 170000 900000 180000 196000 
% total plasma Ig 73 19 7 1 0.001 
Subcksses 4(Ig 14) 2(IgA 1-2) None None None 
Complement Yes Yes Yes No No 
activation 
Sedimentation 6.7S 7.1S 19S 7.0S 8.0S 
coefficient 
LightK:hain isotype icand X K and X Kand X K and \ Kand X 
Placental transfer Yes No No No No 
Half-iife 21 days 5.8days 5.1 days 2.8 days 2.3 days 
Approx. mean 10 2.0 1.0 0.0003 0.03 
normal adult conc. 
(g/Hter) 
Daily synthetic 33 24 6.7 0.4 0.02 
5 
antigen binding ability of the antibody. But each variable residue is not involved 
equally in the process of antigen binding and three subregions stand out as being 
'hypervariable'. The hypervariable regions of light and heavy chains are the regions 
specifically responsible for the binding of the antigen, for that individual 
immunoglobulin molecule. The remainder of the molecule, which is not involved in 
antigen recognition, is named the 'constant region' and is identical to other 
immunoglobulin molecules of the same class, subclass, and allotype. The region 
between the antigen binding part of the immunoglobulin and the constant part is the 
hinge region. The length of the hinge region varies between the immunoglobulin 
classes and subclasses. 
In light chains, there are two intrachain disulphide bridges and there are four of such 
bridges in heavy chains. A peptide loop of 60-70 amino acid residues is enclosed in 
each bridge, and a high degree of sequence homology between sections of peptide 
chains is contained within the disulphide bridged loops. These regions are indicated 
by a specific name which is 'homology' regions. Each homology region is folded in a 
compact globular structure or domain and each domain plays a particular biological 
role. Both IgM and IgA have the propensity to form polymers. 
Two-thirds of serum light chains are K and one-third X. They have a molecular 
weight of22000 Daltons and 210-220 amino acids and contain a constant and variable 
region. The variable region extends from the amino terminal for approximately 110 
amino acids and is responsible for the unique thermal solubility and antigen binding 
properties [7]. 
6 
Light chains may play a role in immunoregulation of the immune response and they 
are catabolized by the kidney. Clyne postulated that nephrotoxicity is related to the 
isoelectric point in 1979 with cationic light chains being more nephrotoxic than 
anionic chains [9，10，11]. The ratio offree light chains KiX in the serum may play an 
important role in monitoring and provides earlier warning of myeloma 
progression[76]. 
1.2.2 Properties of immunoglobulins 
(i) IgG 
There are four subclass of normal human IgG. IgGl and IgG3 fix complement by 
the classical pathway, while IgG2 and IgG4 do not. Other varying properties of the 
IgG subclass include the presence of the receptor for macrophages (IgGl and IgG3) 
and the failure to react with staphylococcal A protein (IgG3). IgGl antibodies are 
against isoagglutinins and viruses, while IgG2 antibodies are detected against 
polysaccharides. IgG4 antibodies act in the circulating anticoagulants against 
coagulation factors viii and ix. All classes of IgG cross the placenta and are 
responsible for passive immunity in the newborn. IgG interacts with the Fc receptors 
on neutrophils, monocytes, and macrophages. The plasma IgG level rises slightly later 
in response to soluble antigens such as bacterial toxins. The IgG molecules can 
diffuse fairly freely into the interstitial fluid and act in the tissue against infection. 
They may be detected in a raised level and as a diffusely increased y band on the 
electrophoresis strip within a few weeks of the initial infection. 
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(ii) IgM 
The characteristic structure ofIgM is shown in Fig. 2. There are five H2L2 subunits 
in the IgM molecule which is a pentamer shape. IgM antibodies are the first to appear 
in the immune response and are quite effective in the activation of complement by the 
classical pathway. They have low molecular weight and low concentrations in normal 
serum. They are almost confined to the intravascular compartment since they are 
large. This makes them the first line of defense amongst immunoglobulins against 
infection. IgM is the major protein found on the surface ofB-lymphocytes. 
(iii) IgA 
IgA is produced adjacent to secretary surfaces such as intestinal, respiratory tracts, 
sweat glands on the skin, etc. It is affected more than other immunoglobulins in 
disease of the gastrointestinal and respiratory tracts. Most IgA is monomeric, although 
approximately 15 per cent of serum IgA circulate as a dimer linked by a joining or J 
chain (Fig. 3). The J chain combines covalently with the H chain of IgA (and IgM) 
and is structurally unrelated to heavy and light immunoglobulin chains. Secretory IgA 
differs from serum IgA in its association with a peptide chain called the secretary 
component. The role of this secretory component is to increase the resistance of the 
IgA molecule to the proteolytic digestion in secretions such as those in the digestive 
system. Secretory IgA has a molecular weight of 380000 and the complete molecule 
is a dimer of IgA together with a J chain and secretary component. Secretory IgA has 
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Rowe and Fahey first described IgD in a patient with myeloma in 1965. It is found 
on the surface ofmost B lymphocytes, although present in normal serum in very small 
amounts (less than 1 per cent of the total serum Ig ). Ninety per cent of the normal 
serum IgD, and IgD myeloma paraproteins are of X light-chain isotype. Surface IgD is 
usually found in association with IgM and, in this situation, both molecules have the 
same VH and VL regions [12,13]. The role of IgD in normal immune regulation is 
still unknown. 
(v) IgE 
The serum level of IgE is low because of a very low synthetic rate and short 
intravascular half-life. IgE is synthesized by plasma cells beneath the mucosae of the 
gastrointestinal and repiratory tracts and by those in the lymphoid tissue of the 
nasopharynx. It is the reaginic antibody of man and these antibodies mediate the 
wheal and flare reactions and are often present in high allergic individuals. It is 
present in nasal and bronchial secretions. Combination of antigen results in the cell 
releasing mediators and accounts for immediate hypersensitivity reaction such as 
occur in hay fever. The level of IgE is raised in several disease with an allergic 
component such as in some cases of asthma, eczema and parasitic infestation. 
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1.3 Monoclonal proteins and monoclonal gammopathies 
(1.3.1) Monoclonal proteins 
Monoclonal proteins result from the over-production of immunoglobulin molecules 
by plasma cells and lymphocytes and are the hallmark of multiple myeloma and 
related conditions [7]. They may arise from malignancies of B cell origin or result 
from hyperstimulation of one or a few normal clones giving rise to single 
(monoclonal) bands on electrophoresis. The clinical laboratory importance of 
monoclonal proteins lies in their use as tumor markers for the diagnosis and 
monitoring of malignancies o f B cell origin [44, 59]. In malignant diseases, they are 
usually associated with myeloma, lymphoma and chronic lymphocytic leukaemia 
[53]. However, the presence of a monoclonal protein per se is not only a marker of 
malignancy, and several benign conditions, such as collagen vascular disease, can be 
associated with monoclonal immunoglobulin production. Monoclonal proteins can 
occur in the elderly apparently without malignant significance (e.g. MGUS or the 
benign paraproteins). It is important to distinguish malignant paraproteins from those 
ofabenign nature which are the products of static or slowly growing clones of a well 
differentiated type. Although some of these diseases are benign, monoclonal protein 
charactererisation and level is required in follow-up investigation because they may 
become to malignant [54, 68-69，71], e.g. 17% at ten years and 33% at twenty years 
ofMGUS eventually progress to malignant, with an annual risk rate of 0.8%[14, 56, 
63], and the presence of kappa light chain is thought to be a risk factor for malignant 
transformation[66]. 
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Monoclonal B cell proliferations in which B lymphocyte maturation is blocked in the 
final stages of the differentiation cycle lead to monoclonal gammopathies [81]. The 
heavy chain gene will be rearranged first during the B lyphopoiesis without antigen, 
and then the K gene. The K rearrangement is abortive in some cells and a X 
rearrangement occurs. Then the cell is committed to a unique variable region 
specificity (the idiotype) and light chain type. It is possible to select different heavy 
chain constant regions so that a cell may change from the synthesis ofIgM to another 
class during maturation, a process called class switching. Immunoglobulin resulting in 
the absence ofantigen is bound on the membrane ofB cell. Antigen may choose those 
B cell clones able to recognize the antigen. After the proliferation of clones, some of 
those B cells are turned into plasma cells while others become memory cells. Plasma 
cells are non-proliferative end cells producing large amounts of secreted 
immunoglobulin. In the high level ofcell proliferation that occurs on contact ofB cell 
with antigen, antibody diversity exists due to the accumulated somatic mutations in 
the variable regions. During immune reaction, in a low antigen concentration, somatic 
mutations resulting in higher affinity of the antibody for antigen will be selected. 
A polyclonal antibody response may due to a large number of different idiotypes 
produced by many different clones in response to even a single antigen results in 
microheterogeneity amongst the immunoglobulin. If there is predominant 
proliferation of a single clone of B cells, the antibody product will be confined to a 
1 3 
single heavy and light chain type and to a single idiotype, leading to a monclonal 
immunoglobulin or paraprotein[2]. 
(1.3.2) Monoclonal gammopathies 
Monoclonal gammopathies are disorders characterized by the proliferation of a 
single clone of cells producing a monoclonal protein (M-component, M-protein, 
paraprotein) [14, 49]. The most common plasma cell disorder is the benign 
monoclonal gammopathy (BMG) or monoclonal gammopathy of undetermined 
significance (MGUS), although multiple myeloma is the most comment malignancy 
in monoclonal gammopathies [14, 17, 78]. A current classification of monoclonal 
gammopathies is shown in Table 2 [14]. 
To make an accurate diagnosis for the patients with monoclonal gammopathies is 
very important. Some of them don't need the treatment while others need to be treated 
immediately [18]. A wrong diagnosis will lead to unnecessary cost or delay of 
treatment. Monoclonal immunoglobulin is the characteristic of these diseases. The 
follow-up investigation of M-protein is necessary even in those benign monoclonal 
gammopathies. 
In monoclonal gammopathies, all plasma cells produce a slight excess of light chains 
which may precipitate in the renal tubules causing renal disease [75]. Malignant B cell 
clones often secrete considerably more than their benign counterparts, resulting in 
detectable amounts of Bence Jones protein in the urine. Bence Jones protein is 
occasionally seen in the serum due to renal failure of filtration by the kidney or in 
cases where very large amounts are produced by the tumor. Monoclonal 
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Tab le 2. C lass i f i ca t ion of monoc lona l gammopa th ies [ref 1] 
MGUS 5 ^ 
Mul t ip le 
Myeloma 18% 
Amylo idos is 10% 
Lymphoma 5% 
SMM 4% 




immunoglobulins may deposit in the body and develop to monoclonal Ig deposition 
disease (MIDD)[50]. Discrete changes in V region sequences are the major cause in 
tissue deposition of human L chains [65]. The presentations are variable due to the 
difference deposition places for paraproteins, e.g. respiratory insufficiency may 
happen due to accumulation of IgG-kappa paraprotein in the alveolar space[70]; 
deposition of paraprotein in small vessels is a cause of skin ulcers in Waldenstrom's 
macroglobulinemia[72] and deposition in kidney leads to renal lesions [75]. The 
precipitation of monoclonal immunoglobulin is also related to the type I and type II 
cryoglobulinemia because monoclonal IgM, IgG, and IgA may be shown to 
cryoprecipitate when they are exposed below 37°c [58], Neuropathy was found in 
some monoclonal gammopathies associated with IgG, IgA and IgM [67, 79]. 
Paraproteins were detected even in systemic capillary leak syndrome [74]. 
The number of clone cells in the blood of patients with monoclonal gammopathies is 
different, e.g. clonal circulating cells of MGUS patients is less than those with 
myeloma [64], Then serum concentration of monoclonal proteins often relates to the 
tumor cell mass in myeloma, Waldenstrom's macroglobulinaemia and alpha-heavy 
chain disease (alpha HCD) and thus may be used for detecting and monitoring these 
disorders [47]. The level of monoclonal proteins is not as useful a prognostic marker 
as the serum beta 2-microglobulin (beta 2-M) level because beta 2-M reflects both 
tumor cell production and the failure of excretion which results from the renal damage 
which has long been known to be an important prognostic feature in myeloma [19]. 
Although it is not always a very good prognostic marker, monoclonal proteins do give 
useful information [18]. For example: type of paraprotein may influence treatment; 
level of monoclonal protein may influence whether therapy is necessary. 
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1.4 Laboratory investigation of monoclonal immunoglobulin 
1.4.1 The current procedure of investigation in this laboratory 
The laboratory investigation of monoclonal immunoglobulin is summarized in Fig. 4 
[41] 
Serum and urine protein electrophoresis is requested when an abnormal protein is 
suspected. Electrophoresis is the first step for detecting monoclonal immunoglobulin 
since it is the simplest and most reliable method. It is widely used in clinical 
chemistry laboratories and became a routine test in the measurement of proteins. But 
it is only the first line of investigation in paraprotein and not adequate for identifying 
the paraprotein [20]. Five main groups of proteins, albumin and the al- , a2-, p-, and 
y-globulins, may be distinguished after staining and compared with those in a normal 
control serum. Each group contains several proteins. Some of the abnormal 
electrophoretic patterns are characteristic of a group of related disorders, while others 
show non-specific pathological processes. Most immunoglobulin species run in y 
range or move into P or a2 range. Electrophoresis may suggest whether a raised 
immunoglobulin concentration represents a monoclonal increase and also demonstrate 
immune suppression, especially of IgG, which usually accompanies malignant 
paraproteinaemia. This is shown by a sharp band representing the monoclonal protein 
that is accompanied by a corresponding decrease in the intensity of staining for the 
remainder of the y region. 
1 7 
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Further investigation should be employed to confirm the presence of monoclonal 
protein and to distinguish the immunoglobulin class. There are several electrophoresis 
techniques generally used in the detection, identification/characterization and 
monitoring of gammopathies. The current methods are immunoelectrophoresis and 
immunofixation [4，19，22, 35]. Both of these methods are the next step for 
confirming a monoclonal immunoglobulin and identifying its type. And the third step 
is quantification of paraprotein by densitometry from the electrophoresis strip [24，25, 
28，30, 36，33, 37，77]. 
Thus the strategy to diagnose monoclonal gammopathies includes electrophoresis of 
serum protein on agarose gel or cellulose acetate; immunoelectrophoresis or 
immunofixation; and quantification of paraprotein [21,26, 51, 80], 
1.4.2 Problems in identifying monoclonal immunoglobulin 
An oligoclonal pattern results if more than one clone of cells in an individual are 
producing significant amounts of "monoclonal" immunoglobulin [52]. It is sometimes 
difficult to distinguish between oligoclonal bands and small monoclonal bands by the 
techniques mentioned above. This is even more of a problem in Hong Kong than 
many other areas because of the high incidence of cirrhosis which is one of the 
conditions associated with oligoclonal bands [55, 84]. 
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1.5 Comparison of different techniques 
1.5.1 Immunoelectrophoresis (IEP) 
Immunoelectrophoresis is a common method in identification of the monoclonal 
protein. Electrophoresis on agarose gel or cellulose acetate separates the various 
proteins. When this has occurred, antibody is applied alongside the full length of the 
electropherogram. Usually, the sample is loaded a number of times on the same gel at 
regular intervals. This allows different antiserum to be applied such as IgG, IgA, IgM, 
K and X between the samples. The precipitin lines or arcs are formed along where the 
antigen and the antibody meet. Most precipitin arcs form within 24 hours. The arcs 
become diffuse and exaggerated if the diffusion is continued for more than 24 hours. 
This will make the interpretation difficult. The immunoelectrophoretic pattern of 
monoclonal protein is shown in Fig.5. The presence of a monoclonal protein is 
indicated by the distortion (thickening or bowing) of an arc caused by the presence of 
a relatively larger amount of protein in one portion of the gel owing to the uniform 
isoelectric point of the monoclonal protein [1]. 
However, it is difficult to monitor by immunoelectrophoresis if monoclonal Ig is 
presence in a low concentration and/or it has a diffuse electrophoresis mobility. IEP is 
not good in detecting oligoclonal Ig since the second dimension in IEP is a diffusion 
step, and not only do the antigens diffuse toward the antiserum, but also diffuse 
towards each other. And this loses much of the resolution obtained during the 
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electrophoretic step [15], The ,umbrella efFect' which is caused by the polyclonal Ig, 
may increase the difficulties in identification of the small monoclonal components in 
immunoelectrophoresis[3 8]. 
1.5.2 Immunofixation 
The method employs electrophoresis in agarose gel or cellulose acetate followed by 
application of specific antibody by overlay of a cellulose acetate strip soaked with the 
specific antibody [16]. The strip is laid on the gel so that it covers the zone in which 
the antigen of interest may be located. After an incubation of 1 h, the strip is removed 
and the gel washed and stained. Antigen and antibody that have formed a precipitate 
are not removed during the washing step, whereas antigens that have not reacted with 
the antibody are soluble and will be removed [23], As for immunoelectrophoresis, the 
sample is usually loaded a number of times to allow fixation with several antibodies 
on a single gel, and one portion of gel may be stained without the immunofixaton step 
to give an electrophoretic pattern for comparison. This allows serum from a patient to 
be characterized with several different antibodies on a single plate. A template may be 
used to apply the antiserum instead of cellulose acetate strips. Fig.6. shows a 
monoclonal protein by immunofixation. 
Immunofixation is a good technique to identify monoclonal protein with greater 
sensitivity and specificity than immunoelectrophoresis [32，39，40]. It may identify 
bands of protein seen on electrophoresis but which are lost on immunoelectrophoresis 
because of diffusion. It also may identify small bands, IgA and IgM [31], which are 
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impossible to see on immunoelectrophoresis[ 15]. The technique of immunofixation is 
easier than immunoelectrophoresis[3 8]. The Paragon JFE system which is made by 
Beckman Instruments Inc is the method used in our laboratory and it is good for 
detecting small monoclonal proteins.[21] 
Oligoclonal bands may still be difficult to distinguish from monoclonal bands even 
using immunofixation although it is a very good technique in identifying paraproteins. 
The method is expensive as more antiserum is used than with immunoelectrophoresis. 
Antigen-excess in immunofixation requires the examination to be repeated with 
several dilutions of serum or antiserum [43]. 
1.5.3 Isoelectric focusing and immunoisoelectric focusing 
In isoelectric focusing, ampholytes, which contain molecules of different pH, are 
added to the agarose or acrylamide gels. When the current is turned on the ampholytes 
migrate until they reach the pH of their isoelectric point [1, 36] and a pH gradient is 
created. Thus the gel consists of a pH increase from anode to cathode in the range of 
ampholytes used in our experiment 3-10. Similarly proteins from the sample migrate 
to their isoelectric points. If they diffuse in either direction they gain or lose a charge 
and move back to their isoelectric points. This results in narrow bands with no 
problem of diffusion and it "concentrates" the sample so it is a more sensitive 
technique than electrophoresis. 
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Isoelectric focusing is a technique of high resolution capable of resolving proteins 
which differ in isoelectric point by as little as 0.001 pH units. 
A single monoclonal band despite the name may show microheterogeneity (multiple 
bands) in isoelectric focusing [15, 34，62, 73], see over 1.3.1. This is due to post-
synthetic modification, and is due to carbohydrate heterogeneity, especially in heavy 
chain disease proteins and changes in the oxidation state of amino acids, particularly 
those containing sulphur, and metal ions resulting in recognizable patterns of bands 
know as the spectrotype. Generally microheterogeneity cannot be detected in 
electrophoresis and immunoelectrophoresis. The width of the band on electrophoresis 
or degree ofcurvature of the arc on immunoelectrophoresis is related to the number of 
bands in the spectrotype. Typically, "narrow" bands have 5-7 lines, and "broad" bands 
can have in excess of 20 lines in isoelectric focusing. Fig.7 shows the monoclonal 
proteins by isoelectric focusing. 
Immunoisoelectric focusing is the most sensitive electrophoretic method described 
in identifying monoclonal proteins [1, 42，61]. This method is about 10-40 times more 
sensitive than immunoelectrophoresis [45]. For monoclonal IgA, IgM, and IgD, 
immunoisoelectric focusing is much more sensitive than either 
immunoelectrophoresis or isoelectric focusing. In Immunoisoelectric focusing, the 
tracks are overlaid with strips of cellulose acetate membrane soaked in specific 
antiserum for 2 h at 37°c after focusing mentioned above similar to 
immunoelectrophoresis is [45]. It is also sensitive in detecting oligoclonal bands [29]. 
As with the immunofixation, there is a high cost in this technique since the antiserum 
is quite expensive. 
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1.6. Aim of the present study 
The current method for investigating samples with abnormal bands is to perform 
immunofixation. Also it is a good method for identifying monoclonal bands, but does 
not always distinguish clearly between monoclonal and oligoclonal bands. Another 
method, as stated above with high sensitivity and specificity for detecting abnormal 
IgG bands is isoelectric focusing, although it is not so good at detecting IgA and IgM 
paraproteins [27]. It cannot therefore be used as the initial screening technique but is a 
good method for identifying oligoclonal and monoclonal IgG. The cost of isoelectric 
focusing should be cheaper than immunofixation because the antiserum is not used. 
The aim of this project was to see if isoelectric focusing without immunofixation 
could help to distinguish between monoclonal and oligoclonal bands, thus reducing 
the number of immunofixations to those patients with monoclonal bands. 
1.7. Design ofExperiments 
50 serum samples were screened by routine electrophoresis. Some of the samples 
had monoclonal bands and others did not. 
The abnormal samples were analysed further by the immunofixation method used in 
the laboratory and the monoclonal proteins were distinguished from those non-
monoclonal proteins which included oligoclonal or polyclonal proteins. 
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The results ofthese samples were unknown to me until after I had made a diagnosis 
independently by isoelectric focusing. Then the results of the two techniques were 
compared. 
The design of experimental is shown in Fig.8. 
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Materials and method 
1. Study subjects 
i) Samples 
Samples were selected by the Scientific Officer from the Protein Unit of the 
laboratory. They were selected with and without monoclonal bands, particularly those 
samples which gave inconclusive results on routine protein electrophoresis and 
required fixation for a definitive diagnosis. 
ii) Storage 
The samples were stored in the freezer with the temperature below 0° C. 
2. Apparatus 
i) Home made ffiF chamber (Fig. 9) 
ii) Power supply 






















































































































































iii) Corning oven for the drying gel 
(75amp) 
iv) Containers for fixative, staining, destainer. 
V) Shaker 
3. Reagents and materials 
i) Templates (Fig. 10) 
Templates were obtained from the Coming ACI electrophoresis system. They were 
modified with "Dymo" tape to provide a template measuring 75xll5x0.75mm as 
described in ref[86]. There are eight wells for samples allowing eight samples to be 
run at the same time. 
ii) Mylar film (FMC lMC BioProducts) 
Gel Bone TM 127mm wide 0.2mm thick and cut to 80mm length. The properties 
were different on both sides of the film. One side has affinity to water, while the other 
side has not. It is important to distinguish these sides correctly. 











































iv) Carrier ampholytes 
(Pharmalytes pH 3-10，Pharmacia Biotech) 
V) Filter paper, absorbent paper. 
vi) Microsample applicators 
vii) Fixative reagent 
A) The "Beckman's" reagent which is used in inmmunofixation. 
B) The reagent was 5% TCA, 35% SSA, 30% Methanol. 50g trichloracetic acid 
and 3.5g sulphosalicylic acid were dissolved in approximately 500ml distilled water. 
300ml methanol was added and made up to lL with distilled water[85-90]. 
viii) Staining reagent 
A) The "Beckman's" reagent which is used in immunofixation. 
B) 0.3% Coomassie Brilliant Blue R in methanolic acetic acid. 0.3g Coomassie 
Brilliant Blue R250 was dissolved in 50ml methanol and 10% glacial acetic was 
added to 500ml with distilled water [60, 85-90], 
ix) Destainer 
A) The Beckman's reagent which is used in immunofixation. 
B) 100ml glacial acetic acid was diluted to 500ml with distilled water and 500ml 
methanol was added [86]. 
x) Distilled water 
3 4 
4.Preparation ofIEF gel 
The gels were prepared as in reference [85-90] but with the following minor 
modifications. 
i) 0.4g agarose was added in 38.0ml distilled water to prepare 6 gels and the weight 
was recorded. 
ii) It was heated in a microwave oven until completely dissolved. It took about 40 
seconds and the temperature was nearly 100 degrees. It was weighed again and 
distilled water was added to make up for water lost by evaporation. 
iii) It was cooled to 55-65^C in a water bath for 10 minutes at least. 
iv) The water bath was 55-65^C, and was also used to warm 2.0ml carrier 
ampholytes, 6 templates and the tubes too. 
V) The carrier ampholytes were added to the agarose solution and swirled to mix 
thoroughly avoiding the creation ofbubbles. 
vi) The agarose solution was distributed into 6 clean tubes. One tube of solution was 
poured onto a template. Immediately the mylar film was applied, hydrophilic surface 
down, to the molten gel, spreading the gel evenly over the template and avoiding 
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entrapment ofair bubbles. The excess agarose solution was allowed to exude from the 
corners. The other tubes were poured in a similar manner. 
vii) The gels were cooled and stored in sealed plastic bags at 4®C. They were 
protected from direct light. Several drops of water were added into the plastic bag to 
protect them from drying. Best results were achieved if the gels were allowed to 
mature for approximately 16 hours, but if necessary they may be used 30 minutes 
after pouring [86]. Gel may be stored for up to one month [86-90]. 
5. ffiF procedure 
i) The mylar film was pulled away from the template starting from one corner. The 
gel adhered to the mylar film. 
ii) The gel was placed on a dark level surface. 
iii) Samples (0.5-1.0ul serum) were applied to the first to sixth sample wells. In the 
eighth channel a haemolysed sample was added in the sample well and a drop was 
added on the other side of the gel. The haemoglobin was used as a visual marker of 
ffiF. In the seventh channel, a known sample with a monoclonal band was added as a 
control to show the ampholytes were working. 
iv) The gel was inverted and placed directly onto the electrodes with the sample wells 
close to the anode. 
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V) It was focused for 210 v.hr at 1.0-1.2watt/gel. The formula, which is used to 
describe the relation of electric power, resistance and current, is: electric power 
(watt)= resistance (voltage) x current (ampere). To keep the electric power in the 
same range, the higher the voltage, the lower the ampere. The initial voltage should be 
150-260v, with a relatively high initial current 7.0-7.5mA to keep the wattage in the 
range. Final voltage approximately increases to 500v and final current approximately 
decreases to 2mA. 
vi) The power pack was turned off allowing the voltage to drop to zero. 
vii) The gel was then acid fixed. 
6. Acid fixation and staining 
i) The gel was placed in fixative for 10 minutes. 
ii) The gel was washed in distilled water for 10 minutes. 
iii) Filter paper was laid onto the gel, avoiding entrapment of air bubbles. Several 
layers of absorbent paper were applied on top, covered with a glass plate and a weight 
of approx. 1 kg was applied for 2 minutes. 
iv) The gel was dried completely by oven for 30-60 minutes. 
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V) It was washed in destainer for 5 minutes. 
vi) Then it was placed in stain for at least 10 minutes. 
vii) Finally it was washed in destainer until background was clear (it took nearly 10 
minutes), avoiding excessive destaining since this may elute stain from some proteins. 
7. Technical factors affecting results 
7.1 The temperature of adding ampholytes 
The ampholytes may be destroyed if the temperature of the agarose is too high 
when the ampholytes are added into the agarose. We made several pieces of gels and 
their temperature was increased to 100°c after adding ampholytes. The same samples 
were added both in the 'normal' gel (ampholytes added in 55-65°c) and abnormal' gel 
(ampholytes added in 100°c). Both of the results were compared after isoelectric 
focusing. 
7.2 The factors in staining 
(i) Reagents 
We used two kinds of staining reagents: Beckman's immunofixation reagents and 
0.3% Comassie Brilliant Blue in methanolic acetic acid. 
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(ii) Ampholytes 
Some gels were not washed and dried thoroughly after ffiF to investigate if the 
ampholytes affect the result in staining. 
7.3 Time 
(i) Time ofIEF 
The time required for focusing was determined by two methods: 1, following the 
number of volt hours the method stated; 2，by watching the focusing of the drop of 
Hb. The time was increased to see if the patterns improved. We did the ffiF in 1.5hr 
and l.Ohr respectively. 
(ii) Time for destainer 
Both fresh and old reagents were used in destainer. The time for destain was 
recorded to have a comparison. 
7.4 The position of the electrode 
The method stated to place the gel with the sample wells near the anode. The gel 
was also placed with the sample wells near the cathode to see if it gives a different 
result. 
7.5 Watt, Voltage and Ampere 
In difference reports, the watt for isoelectric focusing has two difference ranges: 





1. Interpretation of the results in ffiF 
The ampholytes distribute regularly in the track with an increase pI from cathode 
to anode [85-90]. The interpretation of the results does not depend on the exact 
pIs of the bands but their own characteristic appearance. 
1.1 Normal Patterns (Fig. 11) 
The range of the normal patterns (track 1) from the anode to cathode is: al-
antitrypsin in pI 4.2-4.7; albumin in pI 4.7-5.0 and transferrin in pI 5.2. 
Fibrinogen focuses in pI 4-5.5 but is usually not present in a serum sample. 
Polyclonal bands (track 2-7) emerge as a diffuse zone from pH 5-9.5. The pI 
range was selected specifically to give a good separation ofIgG. 
1.2 Monoclonal IgG (Fig. 12) 
The character of monoclonal IgG (track 2, 8) is a wedge-shaped pattern of very 
regularly spaced bands. There is always a wedge with a group of reducing 
intensity bands towards the lower pH region or a 'bidirectional' wedge reducing 
intensity of banding in both directions. Monoclonal IgG may be detected 
anywhere from pI 5 to 9.5. But most of them could be located in the range 7-9.5. 

































































































1.3 Monoclonal IgA (Fig.l3) 
Monoclonal IgAs (track 4) were shown as patterns consisting of large numbers 
of very regular, closely spaced, sharp bands. However, they will also found in 
precipitates (track 6) or partially focused and partially precipitated since they may 
precipitate before reaching their pIs. Residual immunoglobulins were usually 
depressed or not detected, but can be normal. 
1.4 Monoclonal IgM (Fig.l4) 
The monoclonal IgMs (track 3) were characterized by invariably precipitated 
protein before their true pIs were reached. This is caused by not focusing. The pI 
range in which monoclonal IgMs appear as zones of precipitated protein is 4.5-
7.0. The pI range of albumin is 4.7-5.0. Then monoclonal IgM could be on the top 
of albumin and low levels of monoclonal IgMs may not be seen. They may appear 
as: 1, early precipitation in which the whole track looks severely distorted; 2, 
partially focused and 3, as a diffuse zone. 
1.5 Monoclonal free light chains (Fig.l5) 
The pI range for the monoclonal free light chains is 4-10. And their character 
bands (track 5) were sharp and variable. They may appear as a pair of bands 


































































































































































































































1.6 Oligoconal IgG(Fig.l6) 
The pI range of oligoclonal IgG (track 3, 4) is 5-9.5. It is commonly in the 7-
9.5 range. There were several groups of monoclonal IgGs composed in 
oligoclonal IgG. Each group of them has the characteristic wedge-shaped of 
monoclonal IgGs. The overlapping bands between these groups form a track 
which is full of multiple sharp bands. 
2.Factors 
2.1 The temperature of adding ampholytes 
The results were found to be not so good in some of tracks. The patterns were 
not focused well in these tracks. But the others were all right (Fig.l7). Maybe 
only some of the ampholytes were destroyed when the temperature is too high. 
The best temperature condition should be 55-65°c when the ampholytes is added. 
2.2 The factors in staining 
(i) Reagents 
We used the Beckman's immunofixation reagents to fix and stain several gels. 
It was found that the monoclonal bands could be shown clearly. But the pattern of 
albumin could not be found (Fig.l8). That means that immunofixation reagent 
may not ‘fix，albumin although it will 'fix' less soluble proteins such as globulins. 












































































































































































































































































































































































































































































































































































































































































The ampholytes affected the staining procedure greatly if they were not 
washed and dried thoroughly in the oven after isoelectric focusing. Ampholytes 
stained strongly and make the background so blue that you can't interpret the 
result (Fig.l9). The background will not turn back to clear even when destained 
for a long time once this does happen. Drying it again in the oven does not work 
either. 
2.3 Time 
(i) Time ofIEF 
The proteins will not be focused well if there is not enough time for them to 
run. It needs at least l.Ohr for all the proteins to reach their pI. The patterns 
were not better when we prolonged the time to 1.5hr. The suitable time for ffiF 
is l.Ohr. 
(ii) Time for destainer 
The time for destainer is not a constant. It will take a long time in destainer if 
the reagent had been used for several times. The time it took could be vary from 
0.5hr to 24hr according to the times the reagent had been used. It needs only 5 
minutes if the reagent is used for the first time. 
2.4 The position of the electrode 
In theory, it should make no difference with the technique of isoelectric 



















































































found that there was no big difference in the results in practice either. However 
there is smooth space for immunoglobulins to run when the samples are placed 
near the anode. The patterns of immunoglobulins will be interfered by the 
application point if samples are placed near the cathode (Fig.20). 
2.5 Watt,Voltage and Ampere 
We compared the results in two ranges. The patterns in the range of 1.0-
1.2watt slightly were near clear than in 1.0-1.5watt. 
3.Comparison of the results between isoelectric focusing(without antiserum 
fixation) and immunofixation electrophoresis (Table.3). Oligoclonal bands were 
clearly distinguished from monoclonal bands by EEF. There was one case with 
monoclonal IgM missed by isoelectric focusing. Its results of routine 
electrophoresis, immunofixation, and isoelectric focusing are shown on Fig.21 
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Table 3. Comparison of the results beween isoelectric focusing and 
immunofixation electroporesis 
paraprotein 
. Heavy Chains BJP 
no. paraprotein 
IgG IgM IgA J r e e f r ^ 
& b b Kappa Lambda 
Immunofixation ^^  2i 4 7 2 0 
‘ Electrophoresis 
Isoelectric Focusing 
without immunofixation 19 (4 are 
oligoclonal 21 3 7 2 
� bands) 
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Fig.21 Routine electrophoresis of the missed monoclonal IgM 
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Fig.22 CFE ofthe missed monoclonal IgM 
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Fig.23 ffiF ofthe missed monoclonal IgM 
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Chapter 4 
Discussion 
The identification of monoclonal immunoglobulins is important in the 
diagnosis and management of some B cell tumours. It is necessary to detect 
monoclonal proteins in the follow-up investigation of some diseases even 
including the benign monoclonal gammopathies [55,63-66]. But the monoclonal 
proteins cannot be detected clearly when the concentration is low in serum and 
about two-thirds of patients with monoclonal immunoglobulins have low 
concentration in serum (<5 g/L)[41]. In this condition, it is difficult to distinguish 
between oligoclonal bands and small monoclonal bands by routine protein 
electrophoresis. The ability to distinguish these two types ofbands is necessary in 
the clinical laboratory because they indicate different diseases and prognosis 
respectively [55]. The monoclonal proteins are associated with some B cell tumor 
(e.g. myeloma) while oligoclonal proteins commonly relate to infection and other 
causes of chronic immune stimulation such as cirrhosis, rheumatoid arthritis and 
collagen vascular diseases (see 1.3.1). 
Distinguishing small monoclonal from oligoclonal bands is even more of a 
problem in Hong Kong than many other countries because of a high incidence of 
cirrhosis that is one of the conditions associated with oligoclonal bands[55,82]. 
The incidence ofoligoclonal bands in Hong Kong is about three times higher than 
the figure of3% quoted by Kyle[55,69]. 
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In the clinical laboratory, the current methods for identifying and typing the 
monoclonal immunoglobulin after the routine electrophoresis are 
immunoelectrophoresis and immunofixation electrophoresis [41]. However, 
immunoelectrophoresis is not used in many of laboratories because of its low 
sensitivity and specificity, although it was the early technique used in identifying the 
monoclonal proteins. And the most common method used now is immunofixation 
electrophoresis. Immunofixation has high sensitivity and specificity in identifying 
monoclonal proteins but antiserum and instruments are quite expensive. Isoelectric 
focusing is another method with high sensitivity and specificity for detecting abnormal 
IgG bands. But this method is not sensitive for detecting abnormal IgA and IgM bands 
and therefore cannot be used for initial screening. We roughly calculated each 
specimen cost in ffiF and IFE. The cost of one specimen in ffiF includes agarose and 
ampholytes while the cost of one specimen in JFE includes the gel and antiserum. The 
prices of the two methods were compared (Table 4). Obviously, DEF is cheaper than 
immunofixation because expensive antiserum is not required. 
By comparing the results in these two methods, there was agreement between 
the two methods as to which electrophoretic patterns showed no monoclonal band 
ofIgG. There were monoclonal IgG, IgA, IgM and free light chains in samples we 
studied. However it was found that isoelectric focusing distinguished more clearly 
between oligoclonal and monoclonal IgG than routine electrophoresis and 
immunofixation electrophoresis. There was only one case in which isoelectric 
focusing missed a monoclonal IgM detected by immunofixation. In this case, the 
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Table 4. Compar ison of the pr ices between IEF and IFE 
Price (HK^) [ f P l f E “ 
Agarose/geU 4 9 . 4 ‘ “ “ • 
(8 specimens) 
Ampholytes/gel 1 2 9 . 6 “ ~ ~ ‘ “ 
(8 specimens) • 
Ant iserum/gel — 3 8 5 
(1 specimen) 
Pr ice/specimen 2 2 . 3 7 5 3 3 5 
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concentration of paraprotein was low (1.5 g/L) and it was detected only by 
immunofixation, not protein electrophoresis. The sample was fixed because of 
oligoclonal IgG bands present, not because of the IgM bands which was not 
detected. 
There are several classes of monoclonal immunoglobuins including monoclonal 
IgG IgM IgA, IgD, IgE and Bence-Jones proteins. Proportions of each class of 
paraprotein are not equal. Monoclonal IgG has the largest proportion. IgA and 
IgM have a small proportion. There is about 57-59% of patients with myeloma 
which have an monoclonal IgG in the serum, 21-23% have a monoclonal IgA, 1% 
has IgD, and 18% are light chain disease [49,93], In our results, monoclonal IgG 
was the largest proportion of paraproteinaemia and monoclonal IgA and IgM 
relatively had a small proportion. Thus the major paraprotein detected in the 
clinical laboratory is monoclonal IgG which is detected well by isoelectric 
focusing. 
Routine electrophoresis is a good technique to detect all kinds of paraproteins. 
But it's not always good in differentiating oligoclonal from monoclonal bands. 
Therefore immunofixation is necessary and its cost is quite expensive because of 
the antiserum. Isoelectric focusing has a high sensitivity and specificity in 
identifying monoclonal IgG and it distinguishes well between oligoclonal and 
monoclonal bands. Although it is not good in detecting monoclonal IgM and IgA, 
it may be used as a further technique in investigation of paraprotein because 
monoclonal IgG is the most common paraprotein present in serum. Expensive 
instruments and antiserum are not required in isoelectric focusing and the cost is 
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far lower than immunofixation. Immunofixation may then be as a complementary 
test only on patients with a definite monoclonal band. This would avoids the 
waste oflarge sums ofmoney on antiserum and satisfies the clinical requirements 
at the same time. 
I would propose the following scheme (Fig. 24) for investigation abnormal 
bands based in my results. 
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Fig.24 A new scheme for laboratory investigation of monoclonal 
protein based on our results. 
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Isoelectr ic focusing is a technique with high sensit ivi ty and 
specif ic i ty in detecting monoclonal IgG. It dis t inguishes well 
between monoclonal and oligoclonal bands and Its cost is low. 
We recommended this as a cheap method for fur ther 
invest igat ing bands which do not have a typical appearance of a 
monoclonal band. It can reduce the number of samples which 
require immunofixat ion. 
6 5 
Reference 
1. 0. Ross McIntyre. Laboratory investigation of myeloma. James S. Malpas, Daniel 
E. Bergsagel and Robert A. Kyle. Myeloma biology and management. OXFORD 
MEDICAL PUBLICATIONS, 1995. pl91-221. 
2. William J. Marshall and Stephen K. Bangert. Clinical Biochemistry. 
P.Riches:Paraproteinaemias. Pp493-506. New York, Churchill Livingstone,1995. 
3. Richie, R.F. and Smith, R. (1976a). Immunofixation. I. General principles and 
application to agarose electrophoresis. Clinical chemistry,22,487-9 
4. Richie, R.F. and Smith, R. (1976b). Immunofixation. III. Application to the study 
ofmonoclonal proteins. Clinical chemistry,22,1982-85 
5. Sinclair, D.，Kumararatne, D.s.，Forrester, J.b. Lamont, A. and Stott, D.I. (1983). 
The application of isoelectic focusing to routine screening for paraproteinmia. 
Journal ofClinical Pathology, 37，225-62. 
6. Sinclair, D.，Kumararatne, D.S., and Stott, D.I.(1984). Detection and identification 
of serum monoclonal immunoglobulin by immunoisoelectric focusing. Limits of 
sensitivity and use during relapse of multiple myeloma. Journal of Clinical 
Pathology, 37, 255-62 
6 6 
7 D. E. Joshua. Immunoglobulins. James S. Malpas, Daniel E. Bergsagel and Robert 
A. Kyle. Myeloma biology and management. OXFORD MEDICAL 
PUBLICATIONS, 1995, p3-29 
8. Joan F. Zilva, Peter R. Pannall, Philip D. Mayne: Clinical Chemistry in Diagnosis 
and Treatment. Edward Arnorld, 1988. 
9. Clyne, D.H., Amadeo, J.P., and Tompson, R.E. Nephrotoxicity of Bence-Jones 
proteins in the rat: importance of protein isoelectric point. Kidney International, 
1979, 16，345. 
10. Meclion, C., Mougenot, B, Baudouin, B., Ronco, P., Moulongvet-Doleris, L., 
Vanhille, P., et al. Renal failure in myeloma: relationship with isoelectric point of 
immunoglobulin light chains. ClinicalNephrology, 1984，22, 138. 
11.McIntyre, O.R., Kochwa, S., and Propert, K.J.. Prognostic value of light-chain 
isoelectric point (IEP) in myeloma. Proceedings of the American Society of 
Clinical Oncology, 1988, 7，8844. 
12 Vitella E.A. and Uhr, J.W. Immunoglobulin receptors revisited. A model for the 
differentiation of bone marrow derived lymphocytes is described. Science, 189, 
964, 1975 
6 7 
13. Tu, S.M., Winchester, R.J., and Kunkel, H.G. Occurrence ofsurface IgM, IgD and 
free light chains in human lymphocytes. Journal ofExperimental Medicine, 1974, 
139，451. 
14. Joan Blade and Robert A. Kyle. Monoclonal gammopathies of undetermined 
significance. James S. Malapas, Daniel E. Bergsagel and Robert A. Kyle. 
Myeloma biology and management. OXFORD MADICAL PUBLICATIONS. 
1995, P433-476. 
15. F.N. Cornell, R. Mc Lachlan. Idsoelectric focusing in the investigation of 
gammopathies. The clinical biochemistry, 31-37, September, 1985. 
16. Ritchie, R.F. and Smoth, R.. Immunofixation. I. General principles and 
application to agarose electrophoresis. Clinical Chemistry, 22，p497-9 
17. Barlogie B: Plasma cell myeloma, in Beutler E, Lichtman MA, Coller BS, et 
al(eds): William's Hematology (ed5). Batilmore，MD, McGraw-Hill, 1995, p 
1109-1126 
18. P. R. Greipp. Monoclonal gammopathies: new approaches to clinical problems in 
diagnosis and prognosis. Blood reviews (1989) 3, p222-236 
19. j T Whicher, j Calvin, P Riches and C Warren. The laboratory investigation of 
paraproteinaemia. Ann Clin Biochem 1987; 24; pl 19-132 
6 8 
20. J T Whicher and C E Spence. Serum protein zone electrophoresis--an outmode 
test? Ann Clin biochem 1987; 24: 133-139 
21. Samuel Y. Chu, Janet E. Macleod, Lewis Bocci, and Mabel Monteith. 
Characterization of small monoclonal protein bands with Beckman's "Paragon" 
immunofixation system. Clinical Chemistry, Vol.33, No.4, 1987，p617 
22. J T Whicher, M. Wallage, and R. Fifield. Use of immunoglobulin heavy- and 
light-chain measurement compared with existing techniques as a means of typing 
monoclonal immunoglobulins. Clin Chem. 33/10，1771-1773(1987) 
23. A. Myron Johnson, M. D. Immunofixation following electrophoresis or isoelectric 
focusing for identification and phenotyping of proteins. Annals of clinical and 
laboratory science, Vol. 8，No. 3,195-200, 1978 
24. Devery A. Howerton, Irene J. Check, and Robert L. Hunter. Densitometric 
quantitation of high resolution agarose gel protein electrophoresis. Am J Clin 
Pathol, February 1986，213-218 
25. David Stemerman，Christine Papadea, David Martino-Saltzman, A. Christine 
Connel, Barbara Demaline, and Garth E. Austin. Precision and reliability of 
paraprotein determinations by high-resolution agarose gel electrophoresis. 
A.J.C.P. April 1989，435-440 
69 
26. David F. Keren, Jeffrey S. Warren, and John B. Lowe. Strategy to diagnose 
monoclonal gammophathies in serum: high-resolution electrophoresis, 
immunofixation, and yJ% quantification. Clin. Chem. 34/11，2196-2201(1988) 
27. David E. Normansell. Comparison of five methods for the analysis of the light 
chain type of monoclonal serum IgM proteins. Am J Clin Pathol 1985; 84: 469-
475 
28. P M Dennis, B Biegler and R Papas. Improved measurement of monoclonal 
paraproteins in serum using agarose gel electrophoresis. Ann Clin Biochem 1987; 
24; 73-76 
29. James B. Peter, Karen L. McKeown, and Melkon S. Agoplan. Assessment of 
different method to detect increased autochthonous production of 
immunoglobulins in multiple sclerosis. Am J Clin Pathol, June,1992, 858-868 
30. Tsieh Sun, Shiu-Kee Chan, and Stanley Gross. Evaluation of a high-resolution 
electrophoresis system. Am J Pathol 67: 247-250, 1977 
31. Sidney N. Kahn and Mahin Bina. Sensitivity of immunofixation electrophoresis 
for detecting IgM paraprotein in serum. Clin Chem, Vol. 34/8, 1633-1635(1988) 
32. Julia E. C. Guinan, David F. Kenny and Paul A. Gatenby. Detection and typing of 
paraproteins: Comparison of different methods in a routine diagnostic laboratory. 
Pathology (1989)，21, pp35-4 
7 0 
33. Arnold L. Schultz and Louis M. Fink. What is the most efficient way to evaluate 
immunoglobulins? Clin. Chem. 32/2, 391-2 (1986) 
34. UH Paluch, G Keir, S Moyle, EJ Thompson. Quantification ofbands produced by 
isoelectric focusing using immunoperoxidase. J Clin Pathol 1984; 37: 1172-1176 
35. Frank J. Fasulio, Jr., Herbert A. Fritsche, Jr., Frank J. Liu, and Robert G. 
Hamilton. IgG heavy-chain typing of myeloma by isoelectric focusing immunoblot 
analysis. Clin. Chem. 35/3,364-368 (1989) 
36. Teitz NW. Fundamentals of clinical chemistry. Philadelphia, PA: WB Saunders 
Company, 1987. 
37. Fritsche HA, De Leon E. The determination of serum immunoglobulins by 
automated nephelometric analysis. Am J Med Technl, 1975; 41: 19-28 
38. Giampaolo Merlini, Paola Piro, Franco Pavesi, Renzo Epis, and Francesco 
Aguzzi. Detection and identification of monoclonal components: 
immunoelectrophoresis on agarose gel and immunofixation on cellulose acetate 
compared. Clin. Chem. 27/11，1862-1865 (1981) 
39. Cheryl M. Reichert, Donald F. Everett Jr., Paul I. Nadler, and Nicholas M. 
Papadopoulos. High-resolution zone electrophoresis, combined with immunofixation, 
7 1 
in the detection of an occult myeloma paraprotein. Clin. Chem. 28/11, 2312-2313 
(1982) 
40. Keshgegian, A. A., and Peiffer, P., Immunofixaton as an adjunct to 
immunoelectrophoresis in characterization of serum monoclonal immunoglobulins. 
Clin. Clhim. Acta 110，337-340 (1981) 
41. Sidney N. Kahn. Strategy for diagnosis of monoclonal gammopathies in serum. 
Clin. Chem.35/3,508-509(1989) 
42. T Sheehan, D Sinclair, P Tansey，JR 0 , Donnell. Demonstration of serum 
monoclonal immunoglobulin in a case of non-secretory myeloma by 
immunoisoeIectric focusing. J Clin Pthol 1985; 38: 806-809 
43. Anthony G. W. Norden, Leah M. Fulcher, and Anthony D. Heys. Rapid typing 
serum paraproteins by immunoblotting without antigen-excess artifacts. Clin. Chem. 
33/8, 1433-1436 (1987) 
44. David Sinclair, John H Dagg, Allan McI Mowat, Delphine MV Parrott, David I 
Stott. Serum paraproteins in chronic lymphocytic leukaemia. J Clin Pathol 1984; 37: 
463-466 
45. Sheehan T, Sinclair D, Tansey P，and 0'Donnell JR. Demonstration of serum 
monoclonal immunoglobulin in a case of non-secretory myeloma by 
immunoisoeIectric focusing. J Clin Pathol, 1985 Jul, 38:7, 806-9. 
7 2 
46. David Stemerman, B.A., Christine Papadea, David Martino-Saltzmam, A. 
Christine 0'Connell, Barbara Demaline, and Garth E. Austin. Precision and reliability 
of paraprotein determinations by high-resolution agarose gel electrophoresis. Am J 
Clin Pathol, April 1989，435-440 
47. Rudolf H. Zubler. Key differentiation steps in normal B cells and in myeloma 
cells. Seminars in Hematology, 34/1 1997; 13-22 
48. Pamela G Richies. Pitfalls in investigating proteins-how to avoid them. Chemical 
pathology/immunology. 
49. Robert A. Kyle, Philip R. Greipp. Laboratory medicine series on clinical testing 3. 
The laboratory investigation of monoclonal gammopathies. Moyo Clin Proc 53： 719-
739, 1978 
50. Editorial review. Monoclonal immunolgobulin deposition disease (Randall type) 
relationship with structural abnormalities of immunoglobulin chains. Kidney 
International, Vol. 46 (1994)，965-975 
51. Laboratory investigation of paraproteinaemia. Association of Clinical 
Pathologists; Broadsheet 118: July 1998，776-785 
7 3 
52. Martin E. Gore, Pamela G. Riches, and J. Kohn. Identification ofthe paraproteins 
and clinical significance of more than one paraprotein in serum of56 patients. Journal 
ofClinical Pathology, 1979，32, 313-317 
53. D. Sinclair, J. H. Dagg, A. E. Dewar, A. McI. Mowat, D. M. V. Parrott, G. 
Stockdill and D. I. Stott. The incidence, clonal origin and secretory nature of serum 
paraproteins in chronic lymphocytic leukaemia. British Journal of Haematology, 
1986，64，725-735 
54. Robert A. Kyle. Monoclonal gammopathy of undetermined significance, natural 
history in 241 cases. The American Joumal ofMedicine，May 1978，Vol 64, 814-826 
55. Yvette I. Lolin, John Chow, and Nicholas W.R. Wickham. Monoclonal 
gammopathy of unknown significance and malignant paraproteinemia in Hong Kong. 
Am J Clin Pathol，October 1996，449-456 
56. Regis Bataille. New insights in the clinical biology of multiple myeloma. 
Seminars in Hematology, 34/1, 23-28 (1997) 
57. Peter A. Miescher，Y. P. Huang, and S. Izui. Type II cryoglobulinemia. Seminars 
inHematology, 32/1, 80-85 (1995) 
58. M. Pascual, S. Mach-Pascual，and JA Stiffer. Paraproteins and complement 
depletion: pathogenesis and clinical syndromes. Seminars in Hematology, 43/1, 40-48 
(1997) 
7 4 
59. Walters MT, Stevenson FK, Herbert A, Crawly MI, Smith JL. Lymphoma in 
Sjogren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a 
means of tumor monitoring. Scand J Rheumatol Suppl, 1986，61: 114-7 
60. Gallo P, Braco F，Tavolato B. Detection of IgG oligoclonal bands in 
unconcentrated CSF by means ofagarose isoelectric focusing, double immunofixation 
peroxidase staining and avidin-biotin amplification. Ital J Neurol Sci, 1985 Sep, 6:3， 
275-82 
61. Sheehan T，Sinslair D, Tansey P, 0'Donnell JR. The potential value of immuno-
isoelectric focusing in the diagnosis and management of solitary plasmacytoma. Clin 
Lab Haematol, 1985，7:4, 375-7 
62. Schipper HI, Bertram G, Kaboth U. Microheterogeneity of paraproteins. I. 
Diagnostic value of isoelectric focusing followed by immunoblotting. Clin Chim 
Acta, 1988 Feb 15, 171:2-3, 271-8 
63. Pasqualetti P, Festuccia V，Collacciani A, Casale R. The natural history of 
monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 
263 cases. Acta Hematol (Switzerland) 1997 97(3) pl74-9 
64. Billadeau D, Van Ness B, Kimlinger T，Kyle Ra, Terneau TM, Greipp PR. Clonal 
circulating cells are common in plasma cell proliferative disorders: a comparison of 
7 5 
monoclonal gammopathy of undetermined significance, smoldering multiple 
myeloma, and active myeloma. Blood，Jul 1996 88(1) P289-96 
65. Khamlichi AA, Rocca A, Touchard G, Aucouturier P, Preud'homme JL, Cogne M 
.Role of light chain variable region in myeloma with light chain deposition disease: 
evidence from an experimental model. Blood, Nov 15 1995 86(10) p 3655-9 
66. van de Poel MH, Coebergh JW, Hillen HF. Malignant transformation of 
monoclonal gammopathy of undetermined significance among out-patients of a 
community hospital in southeastern Netherlands. Br J Haematol Sep 1995 91 (1) 
pl21-5 
67. Barbieri S, Sandroni P, Nobile-Orazio E, Cappellari A, Cavestro C. Small fibre 
involvement in neuropathy associated with IgG, IgA and IgM monoclonal 
gammopathy. Electromyogr Clin Neurophysiol, Jane-Feb 1995 35(1) p39-44 
68. Simmons Z，Albers JW, Bromberg MB, Feldman EL. Long-term follow-up of 
patients with chronic inflammatory demyelinating polyradiculoneuropathy, without 
and with monoclonal gammopathy. Brain, April 1995 118 (Pt 2) p359-68 
69. Kyle RA. Monoclonal gammopathy ofundetermined significance. Blood Rev, Sep 
1994 8 (3)pl35-41 
7 6 
70. Meijer WG, Van Marwijk Kooy M, Ladde BE. A patient with multiple myeloma 
and respiratory insufficiency due to accumulation of paraprotein in the alveolar space. 
Br J Haematol, Jul 1994 87(3) p663-5 
71. Kampe CE, Hart S, Miller RA, Lichtenstein A, Kyle RA, Berenson JR. 
Expression of shared idiotypes by paraproteins from patients with monoclonal 
gammopahty of undetermined significance. Br J Haematol, Aug 1994 87(4) p719-24 
72. Wagner DR, Eckert F, Gresser U, Landthaler M, Middeke M, Zollner N. Deposits 
of paraprotein in small vessels as a cause of skin ulcers in Waldenstrom's 
macroglobulinemia. Clin Investig, Dec 1993 72(1) p46-9 
73. Harrison HH, Miller KL, Abu-Alfa A, Podlasek SJ. Immunoglobulin clonality 
analysis. Resolution of ambiguities in immunofixation electrophoresis results by high-
resolution, two-dimensional electrophoretic analysis of paraprotein bands eluted from 
agarose gel. Am J Clin Pathol, Nov 1993 100 (5) p550-60 
74. Zhang W, Ewan PW, Lachmann PJ. The paraproteins in systemic capillary leak 
syndrome. Clin Exp Immunol, Sep 1993 93(3) p424-9 
75. Sanders PW, Herrera GA. Monoclonal immunoglobulin light chain-related renal 
diseases. SeminNephrol, May 1993 13(3)p324-41 
7 7 
76. Nelson M, Brown RD, Gibson J, Joshua DE. Measurement of free kappa and 
lambda chains in serum and the significance of their ratio in patients with multiple 
myeloma. Br J Haematol, Jun 1992 81(2) o223-30 
77. Kyle RA. Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North 
Am, Apr 1992 6(2) p347-58 
78. Choo-Kang E, Campbell M. Biochemical abnormalities in multiple myeloma. 
West Indian Med J, Dec 1991 40(4) pl70-2 
79. Bleasel AF, Hawke SH, Pollard JD, McLeod JG. IgG monoclonal 
paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry, Jan 
1993 56(l)p52-7 
80. MacNamara EM, Whicher JT. electrophoresis and densitometry of serum and 
urine in the investigation and significance of monoclonal immunoglobulins. 
Electrophoresis, May 1990 11(5) p376-81 
81. Ricci C，Cascio G, Canavera R, Basso M, Baldassi R. Immunoregulation and 
differentiation markers in monoclonal gammopathies. Acta Haematol, 1987 78 Suppl 
1 p50-5 
82. Gibson JB; Wu Pc; Ho Jc; Lauder IJ. Hepatitis B surface antigen, hepatocellular 
carcinoma and cirrhosis Hong Kong: a necropsy study:1963-1976. Br J Cancer, 1980 
Sep, 42:3, 370-7 
7 8 
83. Steven M. Rosen, Joel N. Buxbaum, and Blass Frangione. The structure of 
immunoglobulins and their genes, DNA rearrangement and B cell differentiation, 
molecular anomalies of some monoclonal immunoglobulins. Seminars in Oncology, 
13/3 (Sep), 1986 p260-274 
84. Guinan JE, Kenny DF, Gatenby PA. Detection and typing of paraproteins : 
comparison of different methods in a routine diagnostic laboratory. Pathology, 1989 
Jan,21:l,35-41 
85. Detection of oligoclonal IgG in CSF by immunoblotting following isoelectric 
focusing. The Clinical Biochemist, November 1989, p70-l 
86. Isoelectric focusing. The Clinical Biochemist, Novemberl989, p64-5 
87. McLachlan R. Isoelectric focusing of immunoglobulins- an altas of patterns. Clin 
Biochem Monogr, Sep 1985; p38-52 
88. Cornell FN, McLachlan R. Isoelectric focusing in the investigation of 
gammopathies. In: Monograph advanced electrophoretic techniques for protein 
investigation in clinical diagnosis. The clinical Biochemist, Sep 2985, p31-7 
89. Isoelectric focusing-Principles and Methods. Pharmacia Fine Chemicals 
Handbook. 
7 9 
90. Righetti PG. Isoelectric focusing: theory, methodology and applications. Work TS 
and Burdon RH eds. Laboratory Techniquea in Biochemistry and Molecular Biology 
Vol. II. Amsterdam, Elsevier Biomedical, 1983. 
8 0 
{ 
. . ) , . . .:...�,-.i:ii:^i^ii^i^：^^: 
C U H K L i b r a r i e s 
_ _ l _ l l 
DD37D5Dbl 
